Open AccessCombined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
Author(s) -
Chiung-Yi Chiu,
Tzu-Lun Huang,
PoYuan Chang,
Fang-Ting Chen,
Yung-Ray Hsu,
YunJu Chen,
JiaKang Wang
Publication year - 2021
Publication title -
taiwan journal of ophthalmology
Language(s) - English
Resource type - Journals
eISSN - 2211-5072
pISSN - 2211-5056
DOI - 10.4103/tjo.tjo_31_20
Subject(s) - medicine , ranibizumab , diabetic macular edema , ophthalmology , refractory (planetary science) , triamcinolone acetonide , macular edema , diabetic retinopathy , diabetes mellitus , surgery , retinal , bevacizumab , chemotherapy , physics , astrobiology , endocrinology
The purpose of this study is to compare the efficacy of intravitreal ranibizumab (IVR) alone and concurrent IVR with posterior subtenon triamcinolone acetonide (PSTA) injection for patients with diabetic macular edema (DME) refractory to IVR monotherapy.